Medtronic tops quarterly profit estimates as demand for heart devices surges
Medtronic beat quarterly estimates on Tuesday due to high demand for heart devices. The firm reported nine billion dollars in revenue and kept its 2026 outlook.
Insights:
Medtronic plc announced third-quarter financial results today that exceeded Wall Street expectations, fueled by robust demand for heart devices and diabetes monitors. The company reported revenue of $9.02 billion, surpassing the $8.91 billion anticipated by analysts, while adjusted earnings per share (EPS) reached $1.36, ahead of the $1.33 consensus estimate. Following these results, the firm reiterated its fiscal 2026 adjusted EPS guidance of $5.62 to $5.66, reflecting a period of sustained procedural demand that continues to support sales for medtech firms.
